Diferencia entre revisiones de «Template:Hypoglycemia DDX»
Sin resumen de edición |
|||
| Línea 17: | Línea 17: | ||
**[[MI]] | **[[MI]] | ||
*Organ Failure | *Organ Failure | ||
**Hepatic failure | **[[Hepatic failure]] | ||
**[[Renal failure]] | **[[Renal failure]] | ||
*Endocrinopathy | *Endocrinopathy | ||
**[[Adrenal insufficiency]] | **[[Adrenal insufficiency]] | ||
*[[Seizure]] | *[[Seizure]] | ||
*[[Inborn errors of metabolism]] | |||
====Malignancy==== | ====Malignancy==== | ||
*Insulinoma | *Insulinoma | ||
| Línea 33: | Línea 35: | ||
***[[Leukemia]] | ***[[Leukemia]] | ||
***Erythrocytosis | ***Erythrocytosis | ||
***Hemolytic disease | ***[[hemolytic anemia|Hemolytic disease]] | ||
*Post-surgical | *Post-surgical | ||
**[[Gastric bypass surgery|Gastric bypass]] | **[[Gastric bypass surgery|Gastric bypass]] | ||
| Línea 49: | Línea 51: | ||
**Intentional overdose | **Intentional overdose | ||
**Increased availability | **Increased availability | ||
***Hepatic failure | ***[[Hepatic failure]] | ||
***Renal failure | ***[[Renal failure]] | ||
***Drug interaction | ***Drug interaction | ||
Revisión actual - 16:47 28 sep 2019
Hypoglycemia
Drugs
- Anti-hyperglycemic
- Insulin
- Oral secretagogue
- Other
Systemic Illness
- Critical Illness
- Organ Failure
- Endocrinopathy
- Seizure
- Inborn errors of metabolism
Malignancy
- Insulinoma
- Non-islet cell
- Insulin/receptor autoantibodies
- High tumor burden
Other
- Artifactual
- Specimen collection
- Consumption
- Leukemia
- Erythrocytosis
- Hemolytic disease
- Post-surgical
- Gastric bypass
- Gastrectomy
- Pyloroplasty
- Starvation
Precipitants of anti-hyperglycemic induced hypoglycemia
- Decreased glucose
- Missed meal
- Consumption (exercise, illness)
- Increased drug
- Error (patient, provider)
- Intentional overdose
- Increased availability
- Hepatic failure
- Renal failure
- Drug interaction